Scientists test pill to turn back the clock on aging
NCT ID NCT07354620
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests whether a drug called rapamycin can reverse biological aging in 52 healthy adults aged 50-80. Researchers will use a special DNA test to measure changes in biological age over six months. The goal is to see if we can slow or reverse the aging process, which is a major risk factor for many diseases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AIM for Wellbeing
Cincinnati, Ohio, 45236, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your heart hold the key to Alzheimer's prevention?
- The aging Body's hidden water shift: a new study investigates
- Rewiring the veteran brain: could visual training counteract cognitive decline?
- Can a simple walk test reveal hidden health risks in aging?
- A handful of walnuts a day: could it keep the aging mind sharp?
- Shining a light on brain aging: could NIR boost memory?